<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Dev Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin. Dev. Immunol</journal-id>
      <journal-id journal-id-type="publisher-id">CDI</journal-id>
      <journal-title-group>
        <journal-title>Clinical and Developmental Immunology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1740-2522</issn>
      <issn pub-type="epub">1740-2530</issn>
      <publisher>
        <publisher-name>Hindawi Publishing Corporation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24171034</article-id>
      <article-id pub-id-type="pmc">3792542</article-id>
      <article-id pub-id-type="doi">10.1155/2013/642643</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary Biliary Cirrhosis-Specific Antimitochondrial Antibodies in Neonatal Haemochromatosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Smyk</surname>
            <given-names>Daniel S.</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mytilinaiou</surname>
            <given-names>Maria G.</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grammatikopoulos</surname>
            <given-names>Tassos</given-names>
          </name>
          <xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Knisely</surname>
            <given-names>A. S.</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8215-4489</contrib-id>
          <name>
            <surname>Mieli-Vergani</surname>
            <given-names>Giorgina</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bogdanos</surname>
            <given-names>Dimitrios P.</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vergani</surname>
            <given-names>Diego</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="I1"><sup>1</sup>Institute of Liver Studies, GI and Nutrition Centre, King's College London School of Medicine at King's College Hospital, Denmark Hill Campus, London SE5 9RS, UK</aff>
      <aff id="I2"><sup>2</sup>Paediatric Liver, GI and Nutrition Centre, King's College London School of Medicine at King's College Hospital, Denmark Hill Campus, London SE5 9RS, UK</aff>
      <aff id="I3"><sup>3</sup>Department of Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Biopolis, Larissa, Greece</aff>
      <author-notes>
        <corresp id="cor1">*Dimitrios P. Bogdanos: <email>dimitrios.bogdanos@kcl.ac.uk</email></corresp>
        <fn fn-type="other">
          <p>Academic Editor: Yehuda Shoenfeld</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>9</month>
        <year>2013</year>
      </pub-date>
      <volume>2013</volume>
      <elocation-id>642643</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Daniel S. Smyk et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
<italic>Background and Aim</italic>. Neonatal hemochromatosis (NH) is characterised by severe liver injury and extrahepatic siderosis sparing the reticuloendothelial system. Its aetiology is obscure, although it has been proposed as an alloimmune disease, resulting from immunological reaction to self-antigens (alloantigens) which the body recognizes as foreign. We studied an infant with NH and his mother whose sera contained antimitochondrial antibody (AMA), the hallmark of primary biliary cirrhosis (PBC). <italic>Material and Methods</italic>. To investigate the origin of AMA in the infant, we studied isotype distributions in serum from the mother and infant. Serum samples were obtained at diagnosis of NH, after liver transplantation (LT; age 1 month), and over the ensuing 17 months. <italic>Results</italic>. At NH diagnosis, infant and maternal serum contained AMA of the IgG isotype, predominantly of the G3 and G1 subclasses. AMA strongly reacted against the pyruvate dehydrogenase complex E2 subunit (PDC-E2), the major PBC-specific AMA autoantigen. Anti-PDC-E2 responses in both infant and mother declined over time, being present 2 months after LT (mother and child) and absent 10 months later (mother) and 17 months later (child). <italic>Conclusion</italic>. The association of maternally transferred IgG1 and IgG3 subclass AMA with the appearance of liver damage in an infant with NH may suggest a causal link between antibody and liver damage.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>1. Introduction</title>
      <p>Neonatal haemochromatosis (NH) is a rare condition of unknown aetiology characterised by perinatal liver failure and extrahepatic siderosis sparing the reticuloendothelial system [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. No genetic or infectious factors have been identified to explain its recurrence rate of 60&#x2013;80% in pregnancies that follow an index case [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>]. The recent suggestion that NH is an alloimmune disease is based on a recurrence pattern similar to that of other alloimmune diseases, on the ability of administration of intravenous immunoglobulin during pregnancy substantially to ameliorate or even to prevent fetal liver disease in siblings of an index patient, and on the demonstration that patient hepatocytes bear assembled components of the terminal complement cascade pathway together with IgG of maternal origin [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>A direct proof that NH is alloimmune is missing since no target has been identified for the putative alloantibody [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>]. Autoantibodies of maternal origin, such as anti-Ro and anti-La, have been described in some children with NH [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>]. The relevance of these antibodies, which are not liver specific [<xref ref-type="bibr" rid="B18">18</xref>], to the pathogenic process in NH is unclear, although they have been associated with liver disease in rare cases [<xref ref-type="bibr" rid="B19">19</xref>]. </p>
      <p>We investigated an infant with NH whose serum contained antimitochondrial antibody (AMA), the hallmark of primary biliary cirrhosis (PBC), a disease with a striking (&gt;95%) female preponderance typically affecting middle-aged women [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>]. We describe the characteristics of the AMA found in this infant, demonstrate its maternal origin, and discuss its potential relevance to the development of NH.</p>
    </sec>
    <sec id="sec2">
      <title>2. Material and Methods</title>
      <sec id="sec2.1">
        <title>2.1. Subjects</title>
        <p>Serum samples from a mother and her infant, who had NH, were obtained. This was the first pregnancy of a 27-year-old of Eastern European origin with no significant medical history complicated by oligohydramnios, symmetrical intrauterine growth retardation, and reduced fetal movements. After spontaneous labour at term she was delivered vaginally of a boy weighing 2.270&#x2009;kg (small for gestational age; &lt; second centile) with a head circumference of 33&#x2009;cm (&lt;0.4 centile). Apgar scores were not recorded and the placenta was not examined; the infant was described as in good condition. Left hip dislocation was noted.</p>
        <p>Evaluation for poor feeding and hypoglycaemia at age 2 days identified jaundice with coagulopathy [INR 2.3, normal value (nv) &lt;1.2], resistant to parenteral vitamin K. Liver synthetic function was poor [serum albumin 22&#x2009;g/L, normal range (nr): 35&#x2013;50]. Indices of hepatic and renal function declined despite treatment for presumed sepsis and the boy was transferred to the Paediatric Liver Centre at King's College Hospital at 7 days of age. NH was suspected in view of the patient's age, history, and clinical-laboratory test results [serum ferritin 1481&#x2009;ng/mL (nr: 20&#x2013;300), INR 5.37, albumin 26&#x2009;g/L, AST 44&#x2009;IU/L (nr: 10&#x2013;50), ALT 30&#x2009;IU/L (nr: 10&#x2013;50), and total bilirubin 292&#x2009;<italic>&#x3BC;</italic>mol/L (nr: 3&#x2013;20)]. Before blood transfusion, total iron binding capacity was 28&#x2009;<italic>&#x3BC;</italic>mol/l (nr: 50&#x2013;72) and transferrin saturation was 72% (nr: 20&#x2013;50%) in peripheral-blood serum. Serum immunoglobulin concentrations were IgG, 5.53&#x2009;g/L (nr: 5&#x2013;13); IgM, 0.63&#x2009;g/L (nr: 0.05&#x2013;0.2); and IgA, 0.63&#x2009;g/L (nr: 0.01&#x2013;0.08). Autoantibody testing by indirect immunofluorescence and molecular assays revealed the presence of PBC-specific AMA in serum from the child and his mother (see below).</p>
        <p>The diagnosis of NH was confirmed at 12 days of age by microscopy of a lower lip mucosa biopsy specimen, which found haemosiderin granules within submucosal acinar gland cells (<xref ref-type="fig" rid="fig1">Figure 1</xref>). He was treated with intravenous desferrioxamine, sodium selenite pentahydrate, and N-acetylcysteine and was supported with blood and blood-product transfusions. At age 10 and 16 days he was given intravenous immunoglobulin (0.5&#x2009;g/kg), and at 21 days he underwent single-volume exchange transfusion [<xref ref-type="bibr" rid="B22">22</xref>].</p>
        <p>Poor clinical status prompted listing for liver transplantation (LT) at age 12 days. He received a cytomegalovirus mismatched (donor+/recipient-) split liver allograft at age 30 days. Examination of the explanted liver found postnecrotic cirrhosis with canalicular and hepatocellular cholestasis (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
        <p>He made a slow but steady recovery. Following an isolated episode of lip smacking, and in view of microcephaly he underwent full neurological assessment, which found no cause for seizures; magnetic resonance imaging demonstrated normal brain structures with turricephaly. He was discharged home aged 92 days, 2 months after LT. Hip dislocation was successfully treated at age 10 months with reduction and casting. Allergy to milk, wheat, and egg antigens was diagnosed at age 13 months during evaluation of an urticarial rash. Epstein-Barr virus (EBV) infection was diagnosed at age 16 months (EBV DNA 136,907 copies/mL, blood) and at age 19 months upper respiratory tract infection accompanied fever and widespread lymphoadenopathy (EBV DNA 3,653,748 copies/mL). Adjustment in immunosuppressive regimen was rapidly followed by clinical improvement. Development was normal at age 22 months, without clinical-biochemistry evidence of hepatobiliary disease, although EBV viraemia persisted (EBV DNA 2,169,653 copies/mL). </p>
      </sec>
      <sec id="sec2.2">
        <title>2.2. Autoantibody Testing</title>
        <p>Serum samples obtained from the child at presentation and over the 17 months thereafter (including samples before and after LT) and from the mother at diagnosis of NH in the infant and 4 and 10 months after giving birth were tested for autoantibodies. An informed consent was obtained. Autoantibody testing complied with the principles laid down in the Declaration of Helsinki. Samples were stored at &#x2212;80&#xB0;C until use.</p>
        <p>Autoantibodies were sought by indirect immunofluorescence (IFL) using as substrate rat liver/kidney/stomach tissue (KSL Slide, INOVA, San Diego, CA) and human epithelial (HEp-2) cells (INOVA) at a starting serum dilution of 1/20 to extinction. Autoantibodies to liver and nuclear antigens were tested by a combination of immunoassays including ELISAs (INOVA; EUROIMMUN, L&#xFC;beck, Germany), multiparametric line immunoassay (EUROIMMUN), and Western blot. These assays were based on purified M2 (AMA) antigen from porcine heart mitochondria; on individual human recombinant E2 pyruvate dehydrogenase complex (PDC), branched chain oxoacid dehydrogenase complex (BCOADC), and oxoglutarate dehydrogenase complex (OGDC) expressed in a baculovirus system (DIARECT, Freiburg, Germany); or on extracts from primate liver or from HEp-2 cell nuclei, as described [<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>].</p>
        <p>AMA was initially detected by IFL. It was then characterised by line immunoassay and by an MIT3 ELISA whose target is a hybrid molecule comprising the major epitopes of PDC-E2, BCOADC-E2, and OGDC-E2 combined with native M2 antigen (M2-3E ELISA, EUROIMMUN). To investigate the specificity of the AMA response, reactivity against PBC-specific mitochondrial autoantigens was tested by in house ELISAs. These used recombinant PDC-E2, BCOADC-E2, and OGDC-E2 antigens (DIARECT) as individual targets. Briefly, wells of a flat-bottom plate (MaxiSorp, NUNC, Thermo Scientific, Roskilde, Denmark) were coated in triplicate with individual PDC-E2 (1&#x2009;<italic>&#x3BC;</italic>g/mL), BCOADC-E2 (1&#x2009;<italic>&#x3BC;</italic>g/mL), and OGDC-E2 (2&#x2009;<italic>&#x3BC;</italic>g/mL) diluted in phosphate buffered saline (PBS, Sigma-Aldrich, Coylton, Ayrshire, UK) containing 0.1% bovine serum albumin (BSA) at 37&#xB0;C for 1&#x2009;h. After a blocking step with 2% BSA for 1&#x2009;h followed by 3 washes, serum samples (1/100) in 0.1% PBS/Tween20 (Sigma-Aldrich) were added to the coated wells and the plates were incubated for 1.5&#x2009;h at room temperature on a shaker. After washing (3x), a horseradish peroxidase-conjugated anti-human IgG (INOVA) was added. The plates were held at room temperature for 45 minutes and the chromogenic substrate tetramethylbenzidine (INOVA) was added. The plates were then kept at room temperature for 15&#x2009;min in the dark. Reaction was terminated with 100&#x2009;<italic>&#x3BC;</italic>L/well of 4N H<sub>2</sub>SO<sub>4</sub> and absorbance (optical density, OD) at 450&#x2009;nm was read against blank wells in a microplate reader (MRX, Dynex Technologies). </p>
        <p>IgG subclass-specific anti-PDC-E2 reactivity was investigated by in-house ELISAs, using horseradish peroxidase-labelled anti-IgG1, IgG2, IgG3, and IgG4 (SouthernBiotech, Birmingham, AL), as described [<xref ref-type="bibr" rid="B28">28</xref>]. Each sample was tested in triplicate and the mean optical density was calculated. </p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>3. Results</title>
      <p>At time of presentation to our unit on day 7 of life, the infant's serum contained AMA of the IgG isotype at a titre of 1&#x2009;:&#x2009;80 by IFL; the mother's serum obtained at the same time contained AMA at a titre of 1&#x2009;:&#x2009;320 for IgG and 1&#x2009;:&#x2009;40 for IgM. Other autoantibodies, including anti-nuclear, anti-smooth muscle, anti-liver kidney microsomal, anti-double stranded DNA, and anti-extractable nuclear antigens, could not be demonstrated in either.</p>
      <p>The AMA of infant and mother reacted only with PDC-E2 (<xref ref-type="fig" rid="fig3">Figure 3(a)</xref>) and belonged to the IgG class. The infant autoantibody belonged predominantly to the IgG3 and to a lesser extent to the IgG1 isotype (<xref ref-type="fig" rid="fig3">Figure 3(b)</xref>). There was no anti-PDC-E2 reactivity of the IgM or IgA isotype. A similar anti-PDC-E2 antibody distribution was seen in the mother, with the difference that IgG4 and IgM (1&#x2009;:&#x2009;40) anti-PDC-E2 antibodies also were present (<xref ref-type="fig" rid="fig3">Figure 3(b)</xref>). Concentrations of IgG2 anti-PDC-E2 antibodies were negligible in both mother and infant. At age 4 months (3 months after LT), the child's serum still reacted against PDC-E2, although the antibody titre was lower than that at diagnosis (<xref ref-type="fig" rid="fig3">Figure 3(c)</xref>). Anti-PDC-E2 reactivity also declined in the mother's serum (<xref ref-type="fig" rid="fig3">Figure 3(c)</xref>). Anti-PDC-E2 antibodies were borderline demonstrable in the child at age 10 months and were undetectable in contemporaneously obtained serum from his mother. At age 17 months, anti-PDC-E2 reactivity in the child had declined below the threshold of detectability (OD: 0.2; cut off: 0.24; <xref ref-type="fig" rid="fig3">Figure 3(c)</xref>). IgM- or IgA-class anti-PDC-E2 antibodies were never observed in the child.</p>
    </sec>
    <sec id="sec4">
      <title>4. Discussion</title>
      <p>AMA, a liver-disease-specific autoantibody, is reported here for the first time in an infant with NH. All the evidence indicates that his AMA was of maternal origin, since it belonged to the placenta-crossing IgG class and showed a similar IgG3 and IgG1 pattern in mother and baby [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>]. The mother's serum also contained small quantities of AMA of IgG4 and IgM isotypes, which do not cross the placenta [<xref ref-type="bibr" rid="B29">29</xref>]. Both in mother and baby, AMA targeted PDC-E2, the major AMA antigen in PBC, but was peculiarly unreactive with BCOADC-E2 and OGDC-E2, which in PBC are usually recognised by sera that contain anti-PDC-E2 antibodies [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B31">31</xref>]. </p>
      <p>Whitington and colleagues described <italic>in vitro</italic> binding to hepatocytes by maternal antibodies of the IgG1 and IgG3 isotypes, thought to target liver alloantigens in infants with NH after crossing the placenta [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>]. IgGs isolated from these infants are able to bind to murine hepatocytes and to induce their necrosis through complement activation [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>], an event immunohistochemically reflected in the assembly of the terminal complement components on the hepatocytes of NH infants [<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <p>The AMA present in our mother-baby pair targets PDC-E2, an autoantigen typically recognised by the AMA of PBC patients, and belongs to the complement-fixing IgG3 and IgG1 isotypes, akin to the antibodies described by Whitington [<xref ref-type="bibr" rid="B8">8</xref>]. IgG3 and IgG1 antibodies are particularly efficient at activating the complement system and at recruiting cells bearing the Fc receptors that are capable of phagocytosis and antibody-dependent cell-mediated cytotoxicity [<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>]. Of note is that the ability of AMA to activate the complement system has been described in patients with PBC [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>].</p>
      <p>If the IgG3/IgG1 AMA present in our infant recognised a pathogenetically relevant liver target, as proposed for PBC [<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>], it may have contributed to the development of severe liver damage and failure. </p>
      <p>AMA has been occasionally described in liver disease in paediatric patients. Gregorio et al. reported a girl who at age 12 years developed autoimmune hepatitis with PBC-specific AMA [<xref ref-type="bibr" rid="B39">39</xref>]. AMA persisted throughout the course of her disease despite treatment; the patient died at age 24 years with liver failure, following several episodes of nonadherence to treatment and spontaneous bacterial peritonitis [<xref ref-type="bibr" rid="B39">39</xref>]. More pertinent to our case, placentally transferred PDC-E2-targeting IgG3 and IgG1 AMAs have been reported in 2 infants with acute liver injury that lasted until the antibody disappeared [<xref ref-type="bibr" rid="B28">28</xref>]. </p>
      <p>The AMA present in the mother of our patient with NH is of interest for two reasons: it partially belonged to the IgM isotype, suggesting that it was produced as part of a primary autoimmune response; it declined in concentration over time and eventually disappeared, implying that the triggering autoantigenic stimulus had subsided. A loss of AMA, though occasionally reported, is unusual, since AMA tends to persist once detected, heralding the development of PBC [<xref ref-type="bibr" rid="B40">40</xref>]. The mother of the infant reported here is regularly monitored for a possible reappearance of AMA, especially in the case of a new pregnancy.</p>
      <p>Recent reports show that AMA can be detected in some 40% of patients with acute liver failure when the antibody is sought with a highly sensitive MIT3 ELISA [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>]. In our study an MIT3 ELISA was used to confirm IFL results; it demonstrated AMA in both the infant and his mother. Akin to the AMA characterised in the present study, the AMAs described by Leung et al. using MIT3 ELISA were transient [<xref ref-type="bibr" rid="B41">41</xref>]. Their disappearance was attributed to lack of genetic susceptibility to PBC. The real prevalence and possible involvement of AMA in the causation of the severe liver damage accompanying NH will need to be investigated using similarly sensitive techniques in a series of affected infants.</p>
      <p>Although we cannot definitively link AMA with liver injury in this infant, and NH is not a known complication of pregnancy in women with PBC, no other cause of liver injury was identified. We also cannot rule out AMA as being associated with the liver disease seen in this infant, as the transplacental passage of AMA has been reported in infants with liver injury of unknown cause [<xref ref-type="bibr" rid="B28">28</xref>]. As well, the prevalence of AMA in NH patients and/or their mothers has not been evaluated. </p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Conflict of Interests</title>
      <p>The authors declare that they have no competing interests. </p>
    </ack>
    <ack>
      <title>Authors' Contributions</title>
      <p>Daniel S. Smyk clerked the infant and mother as a medical student in paediatrics, wrote the first draft and contributed to and revised subsequent drafts of the manuscript; Maria G. Mytilinaiou conducted the immunological analysis; Tassos Grammatikopoulos was involved in the clinical management of the patient, and contributed to the writing of the manuscript; A. S. Knisely conducted the histopathological analysis, provided histological images, and contributed to writing and revising the manuscript; Giorgina Mieli-Vergani was involved in the clinical management of the patient and contributed to the writing and revising of the manuscript; Diego Vergani contributed to the writing and revising of the manuscript; Dimitrios P. Bogdanos had the overall supervision of the study, conducted the immunological analysis, was involved in the clinical evaluation of the mother, and contributed to the writing and revising of the manuscript.</p>
    </ack>
    <glossary>
      <title>List of Abbreviations</title>
      <def-list>
        <def-item>
          <term>AMA:</term>
          <def>
            <p> Antimitochondrial antibodies</p>
          </def>
        </def-item>
        <def-item>
          <term>ALT:</term>
          <def>
            <p> Alanine transaminase</p>
          </def>
        </def-item>
        <def-item>
          <term>AST:</term>
          <def>
            <p> Aspartate aminotransferase</p>
          </def>
        </def-item>
        <def-item>
          <term>BCOADC-E2:</term>
          <def>
            <p> Branched-chain oxoacid dehydrogenase complex E2 subunit</p>
          </def>
        </def-item>
        <def-item>
          <term>EBV:</term>
          <def>
            <p> Epstein-Barr virus</p>
          </def>
        </def-item>
        <def-item>
          <term>ELISA:</term>
          <def>
            <p> Enzyme linked immunosorbent assay</p>
          </def>
        </def-item>
        <def-item>
          <term>IgG/A/M:</term>
          <def>
            <p> Immunoglobulin G/A/M</p>
          </def>
        </def-item>
        <def-item>
          <term>IFL:</term>
          <def>
            <p> Indirect immunofluorescence</p>
          </def>
        </def-item>
        <def-item>
          <term>INR:</term>
          <def>
            <p> International Normalised Ratio</p>
          </def>
        </def-item>
        <def-item>
          <term>LT:</term>
          <def>
            <p> Liver transplantation</p>
          </def>
        </def-item>
        <def-item>
          <term>NH:</term>
          <def>
            <p> Neonatal haemochromatosis</p>
          </def>
        </def-item>
        <def-item>
          <term>OGDC-E2:</term>
          <def>
            <p> Oxoglutarate dehydrogenase complex E2 subunit</p>
          </def>
        </def-item>
        <def-item>
          <term>OD:</term>
          <def>
            <p> Optical density</p>
          </def>
        </def-item>
        <def-item>
          <term>PBC:</term>
          <def>
            <p> Primary biliary cirrhosis</p>
          </def>
        </def-item>
        <def-item>
          <term>PDC-E2:</term>
          <def>
            <p> Pyruvate dehydrogenase complex E2 subunit</p>
          </def>
        </def-item>
        <def-item>
          <term>PBS:</term>
          <def>
            <p> Phosphate buffered saline.</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knisely</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Mieli-Vergani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Whitington</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Neonatal hemochromatosis</article-title>
          <source>
            <italic>Gastroenterology Clinics of North America</italic>
          </source>
          <year>2003</year>
          <volume>32</volume>
          <issue>3</issue>
          <fpage>877</fpage>
          <lpage>889</lpage>
          <pub-id pub-id-type="other">2-s2.0-0141459610</pub-id>
          <pub-id pub-id-type="pmid">14562579</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitington</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Gestational alloimmune liver disease and neonatal hemochromatosis</article-title>
          <source>
            <italic> Seminars in Liver Disease</italic>
          </source>
          <year>2012</year>
          <volume>32</volume>
          <issue>4</issue>
          <fpage>325</fpage>
          <lpage>332</lpage>
          <pub-id pub-id-type="pmid">23397533</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelly</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lunt</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism</article-title>
          <source>
            <italic>Journal of Medical Genetics</italic>
          </source>
          <year>2001</year>
          <volume>38</volume>
          <issue>9</issue>
          <fpage>599</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="other">2-s2.0-0034845503</pub-id>
          <pub-id pub-id-type="pmid">11546828</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cox</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Halsall</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Hemochromatosis&#x2014;neonatal and young subjects</article-title>
          <source>
            <italic>Blood Cells, Molecules &amp; Diseases</italic>
          </source>
          <year>2002</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>411</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="other">2-s2.0-0042852936</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoogstraten</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>de Sa</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Knisely</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis</article-title>
          <source>
            <italic>Gastroenterology</italic>
          </source>
          <year>1990</year>
          <volume>98</volume>
          <issue>6</issue>
          <fpage>1699</fpage>
          <lpage>1701</lpage>
          <pub-id pub-id-type="other">2-s2.0-0025241018</pub-id>
          <pub-id pub-id-type="pmid">2110917</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kershisnik</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Knisely</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>C-CJ</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Wittwer</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis</article-title>
          <source>
            <italic>Human Pathology</italic>
          </source>
          <year>1992</year>
          <volume>23</volume>
          <issue>9</issue>
          <fpage>1075</fpage>
          <lpage>1080</lpage>
          <pub-id pub-id-type="other">2-s2.0-0026803430</pub-id>
          <pub-id pub-id-type="pmid">1325409</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitington</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Hibbard</surname>
              <given-names>JU</given-names>
            </name>
          </person-group>
          <article-title>High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis</article-title>
          <source>
            <italic>The Lancet</italic>
          </source>
          <year>2004</year>
          <volume>364</volume>
          <issue>9446</issue>
          <fpage>1690</fpage>
          <lpage>1698</lpage>
          <pub-id pub-id-type="other">2-s2.0-7644235252</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitington</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Neonatal hemochromatosis: a congenital alloimmune hepatitis</article-title>
          <source>
            <italic>Seminars in Liver Disease</italic>
          </source>
          <year>2007</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>243</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="other">2-s2.0-34548127283</pub-id>
          <pub-id pub-id-type="pmid">17682971</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitington</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Malladi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Neonatal hemochromatosis: is it an alloimmune disease?</article-title>
          <source>
            <italic>Journal of Pediatric Gastroenterology and Nutrition</italic>
          </source>
          <year>2005</year>
          <volume>40</volume>
          <issue>5</issue>
          <fpage>544</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="other">2-s2.0-18144376273</pub-id>
          <pub-id pub-id-type="pmid">15861012</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pan</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Melin-Aldana</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Malladi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Whitington</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade</article-title>
          <source>
            <italic>Hepatology</italic>
          </source>
          <year>2010</year>
          <volume>51</volume>
          <issue>6</issue>
          <fpage>2061</fpage>
          <lpage>2068</lpage>
          <pub-id pub-id-type="other">2-s2.0-77952734701</pub-id>
          <pub-id pub-id-type="pmid">20512994</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonilla</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Prozialeck</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Malladi</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neonatal iron overload and tissue siderosis due to gestational alloimmune liver disease</article-title>
          <source>
            <italic>Journal of Hepatology</italic>
          </source>
          <year>2012</year>
          <volume>56</volume>
          <issue>6</issue>
          <fpage>1351</fpage>
          <lpage>1355</lpage>
          <pub-id pub-id-type="other">2-s2.0-84858114934</pub-id>
          <pub-id pub-id-type="pmid">22322235</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knisely</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Vergani</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Neonatal hemochromatosis: a re-vision</article-title>
          <source>
            <italic>Hepatology</italic>
          </source>
          <year>2010</year>
          <volume>51</volume>
          <issue>6</issue>
          <fpage>1888</fpage>
          <lpage>1890</lpage>
          <pub-id pub-id-type="other">2-s2.0-77952691285</pub-id>
          <pub-id pub-id-type="pmid">20512982</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Timpani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Foti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nicol&#xF2;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nicotina</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Nicastro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Is exchange transfusion a possible treatment for neonatal hemochromatosis?</article-title>
          <source>
            <italic>Journal of Hepatology</italic>
          </source>
          <year>2007</year>
          <volume>47</volume>
          <issue>5</issue>
          <fpage>732</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="other">2-s2.0-34848922732</pub-id>
          <pub-id pub-id-type="pmid">17869371</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodrigues</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kallas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nash</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neonatal hemochromatosis&#x2014;medical treatment vs. transplantation: the King&#x2019;s experience</article-title>
          <source>
            <italic>Liver Transplantation</italic>
          </source>
          <year>2005</year>
          <volume>11</volume>
          <issue>11</issue>
          <fpage>1417</fpage>
          <lpage>1424</lpage>
          <pub-id pub-id-type="other">2-s2.0-30444432374</pub-id>
          <pub-id pub-id-type="pmid">16237701</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flynn</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>McKiernan</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Progress in treatment and outcome for children with neonatal haemochromatosis</article-title>
          <source>
            <italic>Archives of Disease in Childhood</italic>
          </source>
          <year>2003</year>
          <volume>88</volume>
          <issue>2</issue>
          <fpage>F124</fpage>
          <lpage>F127</lpage>
          <pub-id pub-id-type="other">2-s2.0-0037373702</pub-id>
          <pub-id pub-id-type="pmid">12598501</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schoenlebe</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Buyon</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Zitelli</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Greco</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Knisely</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins</article-title>
          <source>
            <italic>American Journal of Diseases of Children</italic>
          </source>
          <year>1993</year>
          <volume>147</volume>
          <issue>10</issue>
          <fpage>1072</fpage>
          <lpage>1075</lpage>
          <pub-id pub-id-type="other">2-s2.0-0027377113</pub-id>
          <pub-id pub-id-type="pmid">8213678</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collardeau-Frachon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heissat</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bouvier</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>French retrospective multicentric study of neonatal hemochromatosis: importance of autopsy and autoimmune maternal manifestations</article-title>
          <source>
            <italic>Pediatric and Developmental Pathology</italic>
          </source>
          <year>2012</year>
          <volume>15</volume>
          <issue>6</issue>
          <fpage>450</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="pmid">22901025</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Defendenti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Atzeni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Spina</surname>
              <given-names>MF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical and laboratory aspects of Ro/SSA-52 autoantibodies</article-title>
          <source>
            <italic>Autoimmunity Reviews</italic>
          </source>
          <year>2011</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>150</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="other">2-s2.0-78751610989</pub-id>
          <pub-id pub-id-type="pmid">20854935</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>S-C</given-names>
            </name>
            <name>
              <surname>Shyur</surname>
              <given-names>S-D</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>L-H</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J-Y</given-names>
            </name>
            <name>
              <surname>Chuo</surname>
              <given-names>H-T</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H-C</given-names>
            </name>
          </person-group>
          <article-title>Neonatal lupus erythematosus with cholestatic hepatitis</article-title>
          <source>
            <italic>Journal of Microbiology, Immunology and Infection</italic>
          </source>
          <year>2004</year>
          <volume>37</volume>
          <issue>2</issue>
          <fpage>131</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="other">2-s2.0-3042629223</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Gershwin</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Primary biliary cirrhosis</article-title>
          <source>
            <italic>The New England Journal of Medicine</italic>
          </source>
          <year>2005</year>
          <volume>353</volume>
          <issue>12</issue>
          <fpage>1261</fpage>
          <lpage>1273</lpage>
          <pub-id pub-id-type="other">2-s2.0-25144474552</pub-id>
          <pub-id pub-id-type="pmid">16177252</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogdanos</surname>
              <given-names>D-P</given-names>
            </name>
            <name>
              <surname>Baum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vergani</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Antimitochondrial and other autoantibodies</article-title>
          <source>
            <italic>Clinics in Liver Disease</italic>
          </source>
          <year>2003</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>759</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="other">2-s2.0-0141960202</pub-id>
          <pub-id pub-id-type="pmid">14594130</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rand</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Karpen</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin</article-title>
          <source>
            <italic>Journal of Pediatrics</italic>
          </source>
          <year>2009</year>
          <volume>155</volume>
          <issue>4</issue>
          <fpage>566.e1</fpage>
          <lpage>571.e1</lpage>
          <pub-id pub-id-type="other">2-s2.0-70249151112</pub-id>
          <pub-id pub-id-type="pmid">19560784</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogdanos</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Komorowski</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Disease-specific autoantibodies in primary biliary cirrhosis</article-title>
          <source>
            <italic>Clinica Chimica Acta</italic>
          </source>
          <year>2011</year>
          <volume>412</volume>
          <issue>7-8</issue>
          <fpage>502</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="other">2-s2.0-79551490697</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Shums</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis</article-title>
          <source>
            <italic>Journal of Autoimmunity</italic>
          </source>
          <year>2010</year>
          <volume>35</volume>
          <issue>4</issue>
          <fpage>436</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="other">2-s2.0-77958150189</pub-id>
          <pub-id pub-id-type="pmid">20932720</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rigopoulou</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Bogdanos</surname>
              <given-names>D-P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis</article-title>
          <source>
            <italic>Liver International</italic>
          </source>
          <year>2007</year>
          <volume>27</volume>
          <issue>9</issue>
          <fpage>1226</fpage>
          <lpage>1231</lpage>
          <pub-id pub-id-type="other">2-s2.0-35148835681</pub-id>
          <pub-id pub-id-type="pmid">17919234</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rigopoulou</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Bogdanos</surname>
              <given-names>D-P</given-names>
            </name>
            <name>
              <surname>Liaskos</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis</article-title>
          <source>
            <italic>Clinica Chimica Acta</italic>
          </source>
          <year>2007</year>
          <volume>380</volume>
          <issue>1-2</issue>
          <fpage>118</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="other">2-s2.0-34047168641</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#xE4;hnrich</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pares</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Caballeria</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies</article-title>
          <source>
            <italic>Clinical Chemistry</italic>
          </source>
          <year>2009</year>
          <volume>55</volume>
          <issue>5</issue>
          <fpage>978</fpage>
          <lpage>985</lpage>
          <pub-id pub-id-type="other">2-s2.0-65949104832</pub-id>
          <pub-id pub-id-type="pmid">19264849</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hannam</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bogdanos</surname>
              <given-names>D-P</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>ET</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies</article-title>
          <source>
            <italic>Autoimmunity</italic>
          </source>
          <year>2002</year>
          <volume>35</volume>
          <issue>8</issue>
          <fpage>545</fpage>
          <lpage>550</lpage>
          <pub-id pub-id-type="other">2-s2.0-20244383696</pub-id>
          <pub-id pub-id-type="pmid">12765481</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saji</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Samejima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kamiura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koyama</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Dynamics of immunoglobulins at the feto-maternal interface</article-title>
          <source>
            <italic>Reviews of Reproduction</italic>
          </source>
          <year>1999</year>
          <volume>4</volume>
          <issue>2</issue>
          <fpage>81</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="other">2-s2.0-0033064703</pub-id>
          <pub-id pub-id-type="pmid">10357095</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simister</surname>
              <given-names>NE</given-names>
            </name>
          </person-group>
          <article-title>Placental transport of immunoglobulin G</article-title>
          <source>
            <italic>Vaccine</italic>
          </source>
          <year>2003</year>
          <volume>21</volume>
          <issue>24</issue>
          <fpage>3365</fpage>
          <lpage>3369</lpage>
          <pub-id pub-id-type="other">2-s2.0-0038384134</pub-id>
          <pub-id pub-id-type="pmid">12850341</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogdanos</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Invernizzi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Vergani</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune liver serology: current diagnostic and clinical challenges</article-title>
          <source>
            <italic>World Journal of Gastroenterology</italic>
          </source>
          <year>2008</year>
          <volume>14</volume>
          <issue>21</issue>
          <fpage>3374</fpage>
          <lpage>3387</lpage>
          <pub-id pub-id-type="other">2-s2.0-54349118451</pub-id>
          <pub-id pub-id-type="pmid">18528935</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bruggemann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Bindon</surname>
              <given-names>CI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies</article-title>
          <source>
            <italic>The Journal of Experimental Medicine</italic>
          </source>
          <year>1987</year>
          <volume>166</volume>
          <issue>5</issue>
          <fpage>1351</fpage>
          <lpage>1361</lpage>
          <pub-id pub-id-type="other">2-s2.0-0023621441</pub-id>
          <pub-id pub-id-type="pmid">3500259</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schumaker</surname>
              <given-names>VN</given-names>
            </name>
            <name>
              <surname>Calcott</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Spiegelberg</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller-Eberhard</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Ultracentrifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement</article-title>
          <source>
            <italic>Biochemistry</italic>
          </source>
          <year>1976</year>
          <volume>15</volume>
          <issue>23</issue>
          <fpage>5175</fpage>
          <lpage>5181</lpage>
          <pub-id pub-id-type="other">2-s2.0-0017102773</pub-id>
          <pub-id pub-id-type="pmid">990273</pub-id>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>IgG effector mechanisms</article-title>
          <source>
            <italic>Chemical Immunology</italic>
          </source>
          <year>1997</year>
          <volume>65</volume>
          <fpage>88</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="other">2-s2.0-0031014785</pub-id>
          <pub-id pub-id-type="pmid">9018874</pub-id>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wands</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dienstag</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Bhan</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Feller</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Isselbacher</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Circulating immune complexes and complement activation in primary biliary cirrhosis</article-title>
          <source>
            <italic>The New England Journal of Medicine</italic>
          </source>
          <year>1978</year>
          <volume>298</volume>
          <issue>5</issue>
          <fpage>233</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="other">2-s2.0-0017862197</pub-id>
          <pub-id pub-id-type="pmid">619265</pub-id>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berg</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Doniach</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roitt</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes</article-title>
          <source>
            <italic>The Journal of Experimental Medicine</italic>
          </source>
          <year>1967</year>
          <volume>126</volume>
          <issue>2</issue>
          <fpage>277</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="other">2-s2.0-0014116025</pub-id>
          <pub-id pub-id-type="pmid">4165742</pub-id>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rong</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lleo</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis</article-title>
          <source>
            <italic>Hepatology</italic>
          </source>
          <year>2011</year>
          <volume>54</volume>
          <issue>1</issue>
          <fpage>196</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="other">2-s2.0-79959549320</pub-id>
          <pub-id pub-id-type="pmid">21488079</pub-id>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuneyama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Van de Water</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>PSC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression</article-title>
          <source>
            <italic>Hepatology</italic>
          </source>
          <year>1995</year>
          <volume>21</volume>
          <issue>4</issue>
          <fpage>1031</fpage>
          <lpage>1037</lpage>
          <pub-id pub-id-type="other">2-s2.0-0028939963</pub-id>
          <pub-id pub-id-type="pmid">7535733</pub-id>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gregorio</surname>
              <given-names>GV</given-names>
            </name>
            <name>
              <surname>Portmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mowat</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Vergani</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mieli-Vergani</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis</article-title>
          <source>
            <italic>Journal of Hepatology</italic>
          </source>
          <year>1997</year>
          <volume>27</volume>
          <issue>4</issue>
          <fpage>751</fpage>
          <lpage>754</lpage>
          <pub-id pub-id-type="other">2-s2.0-0030756614</pub-id>
          <pub-id pub-id-type="pmid">9365052</pub-id>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Norstrand</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Malinchoc</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lindor</surname>
              <given-names>KD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression</article-title>
          <source>
            <italic>Hepatology</italic>
          </source>
          <year>1997</year>
          <volume>25</volume>
          <issue>1</issue>
          <fpage>6</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="other">2-s2.0-0031029761</pub-id>
          <pub-id pub-id-type="pmid">8985257</pub-id>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leung</surname>
              <given-names>PSC</given-names>
            </name>
            <name>
              <surname>Rossaro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>PA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis</article-title>
          <source>
            <italic>Hepatology</italic>
          </source>
          <year>2007</year>
          <volume>46</volume>
          <issue>5</issue>
          <fpage>1436</fpage>
          <lpage>1442</lpage>
          <pub-id pub-id-type="other">2-s2.0-36348950863</pub-id>
          <pub-id pub-id-type="pmid">17657817</pub-id>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernal</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Meda</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bogdanos</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Vergani</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Disease-specific autoantibodies in patients with acute liver failure: the King&#x2019;s College London experience</article-title>
          <source>
            <italic>Hepatology</italic>
          </source>
          <year>2008</year>
          <volume>47</volume>
          <issue>3</issue>
          <fpage>1096</fpage>
          <lpage>1097</lpage>
          <pub-id pub-id-type="other">2-s2.0-40949108859</pub-id>
          <pub-id pub-id-type="pmid">18306217</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="fig1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Granules of stainable iron (haemosiderin) within cytoplasm of epithelium of minor glands of the mucosa of the lower lip. Perls' technique with nuclear fast red counterstain, original magnification 1,000x.</p>
      </caption>
      <graphic xlink:href="CDI2013-642643.001"/>
    </fig>
    <fig id="fig2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Hepatectomy specimen, postnatal age 30 days. Nodularity is apparent. The relatively stroma-poor nodules consisted of hepatocellular parenchyma, sometimes cholestatic. The intervening regions that exhibit more compact connective-tissue elements were sites of hepatocellular loss and stromal collapse, with neocholangiolar transformation of remaining parenchyma. Reticulin, original magnification 40x.</p>
      </caption>
      <graphic xlink:href="CDI2013-642643.002"/>
    </fig>
    <fig id="fig3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Antigen specific anti-mitochondrial antibody (AMA) reactivity in the infant and his mother tested by ELISA. Optical density (<italic>y</italic>-axis) and time elapsed since birth of child (<italic>x</italic>-axis) are indicated.</p>
      </caption>
      <graphic xlink:href="CDI2013-642643.003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
